Swiss National Bank’s Juno Therapeutics, Inc. JUNO Stock Holding History

Swiss National Bank’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-135,700	Closed	-$6.2M	–	2494
2017 Q4	$6.2M	Buy	135,700 +2,200	+2%	+$110K	0.01%	919
2017 Q3	$5.99M	Buy	133,500 +29,200	+28%	+$996K	0.01%	914
2017 Q2	$3.12M	Hold	104,300	–	–	﹤0.01%	1297
2017 Q1	$2.31M	Hold	104,300	–	–	﹤0.01%	1475
2016 Q4	$1.97M	Buy	104,300 +26,400	+34%	+$646K	﹤0.01%	1562
2016 Q3	$2.34M	Sell	77,900 -2,000	-3%	-$62.2K	﹤0.01%	1404
2016 Q2	$3.07M	Buy	79,900 +5,900	+8%	+$245K	0.01%	1189
2016 Q1	$2.72M	Buy	74,000 +14,800	+25%	+$516K	0.01%	1242
2015 Q4	$2.6M	Buy	+59,200	New	+$2.94M	0.01%	1158

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Swiss National Bank's JUNO Position: Q1 2018 in Review

Swiss National Bank sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 135,700 shares — an estimated $6.2M sold.

Swiss National Bank first reported a position in JUNO in Q4 2015 and held it in 9 quarters. The position peaked at $6.2M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Swiss National Bank reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Swiss National Bank sold 135,700 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $6.2M.
Swiss National Bank first reported a position in Juno Therapeutics, Inc. in Q4 2015 and held it in 9 quarters.
Swiss National Bank's Juno Therapeutics, Inc. position peaked at $6.2M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Swiss National Bank's 13F filing for Q1 2018, filed 4 May 2018.